The harmful effect of indoxyl sulfate on neovascularization in chronic kidney disease

Laetitia Dou1, Stéphane Burtey2

  • 1Aix Marseille Université, Inserm, Vascular Research Center of Marseille UMR_S 1076, Marseille, France.

Kidney International
|February 17, 2016
PubMed

Insights

Chronic kidney disease impairs blood vessel formation. Indoxyl sulfate, a toxin, blocks this process by inhibiting key signaling pathways in endothelial progenitor cells.

Area of Science:

  • Nephrology
  • Vascular Biology
  • Molecular Medicine

Background:

  • Patients with chronic kidney disease (CKD) exhibit impaired neovascularization in ischemic tissues.
  • The uremic toxin indoxyl sulfate is implicated in endothelial progenitor cell dysfunction.
  • Limited data exist on indoxyl sulfate's specific effects on neovascularization and its underlying mechanisms.

Purpose of the Study:

  • To investigate the impact of indoxyl sulfate on neovascularization in a CKD model.
  • To elucidate the molecular mechanisms by which indoxyl sulfate affects neovascularization.

Main Methods:

  • Utilized a mouse model of uremia to study neovascularization.
  • Assessed endothelial progenitor cell function and signaling pathways.
  • Investigated the role of hypoxia-induced factor (HIF) signaling.

Main Results:

  • Indoxyl sulfate significantly suppressed neovascularization in uremic mice.
  • Impaired endothelial progenitor cell function was observed.
  • Indoxyl sulfate inhibited the hypoxia-induced HIF/interleukin-10/vascular endothelial growth factor signaling pathway.

Conclusions:

  • Indoxyl sulfate is a key factor contributing to impaired neovascularization in CKD.
  • The inhibition of the HIF/IL-10/VEGF pathway by indoxyl sulfate underlies this impairment.
  • Targeting this pathway may offer therapeutic potential for CKD-related vascular complications.

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
469
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.8K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
927
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
574
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
1.2K
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.1K